| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +905K | 94% | $4.42 | +$4M |
| Sells | 2 | -58K | 6% | $4.94 | -$287K |
| Net | -1 | +847K | 88% | +$3.71M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Nancy A. Simonian | Director | $1.07M | Jun 5, 2024 | ||
| Jason Haas | Chief Financial Officer | $262K | Mar 31, 2024 | ||
| Kristin Stephens | Chief Development Officer | $245K | Mar 31, 2024 | ||
| Gerald E. Quirk | Chief Legal & Compliance Offic | $222K | Mar 27, 2024 | ||
| Conley Chee | President & CEO, Director | $218K | Mar 31, 2024 | ||
| Timothy Tyson | Director | $164K | Jun 5, 2024 | ||
| David Roth | Chief Medical Officer | $137K | -$108K | -44.3% | Apr 3, 2024 |
| Marsha Fanucci | Director | $79.2K | Jun 5, 2024 | ||
| Wirth Peter | Director | $79.2K | Jun 5, 2024 | ||
| Deborah Dunsire | Director | $79.2K | Jun 5, 2024 | ||
| Sue Gail Eckhardt | Director | $79.2K | Jun 5, 2024 | ||
| Andrew M. Oh | Director | $79.2K | Jun 5, 2024 | ||
| Richard A. Young | Director | $52.8K | -$178K | -77.2% | Jun 28, 2024 |
| Srinivas Akkaraju | Director | $52.8K | +$4M | Jun 5, 2024 | |
| Eric R. Olson | Chief Scientific Officer | $29.4K | Jul 17, 2023 | ||
| Mark J. Alles | Director | $28K | Sep 16, 2023 | ||
| Amir Nashat | Director | Jun 1, 2022 | |||
| Phillip A. Sharp | Director | Jun 1, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|